Non-Opioid Pain Treatment Global Market Report 2026
상품코드:1957511
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
비오피오이드계 통증 치료 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 553억 1,000만 달러에서 2026년에는 603억 2,000만 달러에 이르고, CAGR 9.1%로 성장할 전망입니다. 지난 수년간의 성장에는 만성 통증 질환의 유병률 증가, 오피오이드 관련 위험에 대한 인식 증가, 비오피오이드 대체요법의 제한적인 가용성, 정형외과 및 근골격계 수술 증가, 통증 관리를 위한 병원 및 진료소 인프라의 확대 등이 주요 요인으로 꼽힙니다.
비오피오이드진통치료 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 843억 6,000만 달러에 이르고, CAGR은 8.7%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 혁신적인 비오피오이드 치료제의 개발, 통증 관리에 있어 디지털 건강 모니터링 및 원격 의료의 확대, 병용 요법의 도입 증가, 통증 관리에 대한 정부 주도의 노력 강화, 개별화된 통증 관리 및 대체 요법에 대한 투자 증가 등을 꼽았습니다. 예측 기간 동안 주요 동향으로는 비오피오이드 계열 통증 관리 요법의 도입 증가, 의료용 대마초 및 오메가3 지방산 보충제 사용 확대, 외용 및 주사제 진통제 제품의 성장, 병원 및 클리닉의 통증 관리 서비스 확대, 침술 및 TENS(경피적 전기신경자극)와 같은 비약물 요법의 통합 등이 있습니다. 등을 꼽을 수 있습니다.
스포츠 관련 부상 증가는 향후 비오피오이드계 통증치료제 시장 확대에 기여할 것으로 예측됩니다. 스포츠 관련 상해란 스포츠나 운동 중 또는 그 이후에 발생하는 신체적 손상을 말합니다. 이러한 증가 추세는 격렬한 스포츠 및 레저 활동 참여의 확대로 인해 운동선수의 신체적 외상 위험이 높아졌기 때문입니다. 비오피오이드 계열 통증 치료는 강력한 통증 완화 및 부종 감소 효과를 제공하고, 오피오이드 관련 위험을 피하면서 더 빠른 치유, 좋은 이동성, 안전한 지속적인 치료를 지원함으로써 이러한 부상에 도움이 될 수 있습니다. 예를 들어, 2024년 10월 영국의 보험 중개회사인 하우덴 그룹 홀딩스(Howden Group Holdings Ltd.)가 발표한 바에 따르면, 2023-24시즌 유럽 5대 축구 리그의 부상자 수는 4,123명으로 전년 대비 4% 증가했다고 합니다. 이처럼 스포츠 관련 부상이 급증하면서 비오피오이드계 통증치료제 시장의 성장을 견인하고 있습니다.
비오피오이드 진통제 시장의 주요 기업들은 오피오이드 관련 위험과 의존성을 억제하면서 강력한 통증 완화를 보장하기 위해 비오피오이드 경구용 치료제와 같은 약물 제제의 발전을 우선순위에 두고 있습니다. 비오피오이드 경구용 치료제는 오피오이드를 포함하지 않는 경구용 진통제로, 염증 억제, 신경 자극 변화, 특정 수용체 표적화 등 다양한 작용기전을 통해 오피오이드의 전형적인 의존성이나 호흡 장애 없이 통증을 조절합니다. 예를 들어, 2025년 7월 미국 바이오테크 기업 버텍스 파마슈티컬스(Vertex Pharmaceuticals)는 중등도에서 중증의 급성 통증 완화를 위한 획기적인 비오피오이드 치료제인 JOURNAVX를 출시했습니다. 이 혁신적인 치료법은 통증 신호를 정확하게 표적화하고, 안전성이 뛰어나며, 빠르게 작용하는 혁신적인 치료법입니다. 이를 통해 확실한 통증 완화, 의존성 위험 감소, 우수한 환자 결과를 촉진할 수 있습니다. 급성 통증을 앓고 있는 분들을 위한 정밀한 통증 관리를 실현하고, 의존 가능성을 감소시키며, 회복 속도와 삶의 질을 향상시킵니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
A non-opioid pain treatment refers to therapy or medication used to manage pain without involving opioid drugs. These treatments alleviate pain through mechanisms other than opioid receptor activation and include options such as acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), certain antidepressants, anticonvulsants for nerve pain, as well as physical therapies like physiotherapy, exercise, heat or cold therapy, and massage.
The main product types of non-opioid pain treatments include medical cannabis, menthol-containing products, omega-3 fatty acid-containing formulations, botulinum toxins, and capsaicin-derived therapies. Medical cannabis refers to the therapeutic use of the cannabis plant or its extracts to alleviate symptoms or manage various health conditions. Drug classes used in these treatments encompass NSAIDs, acetaminophen, local anesthetics, antidepressants, anticonvulsants, corticosteroids, and others. These treatments are administered through oral, topical, injectable, and other routes and are distributed via hospital pharmacies, retail pharmacies, drugstores, and mail-order pharmacies. Common applications include orthopedic and musculoskeletal pain, postoperative pain, cancer-related pain, neuropathic pain, and other pain-related conditions.
Tariffs have impacted the non-opioid pain treatment market by raising costs of imported medical cannabis products, botulinum toxins, and specialized devices like TENS and acupuncture tools. Segments such as injectable products and high-concentration topical therapies are most affected, particularly in North America and Europe where imports are significant. While tariffs have increased costs and disrupted supply chains, they have also encouraged local manufacturing, domestic R&D, and innovation in cost-effective non-opioid pain treatments.
The non-opioid pain treatment market research report is one of a series of new reports from The Business Research Company that provides non-opioid pain treatment market statistics, including non-opioid pain treatment industry global market size, regional shares, competitors with a non-opioid pain treatment market share, detailed non-opioid pain treatment market segments, market trends and opportunities, and any further data you may need to thrive in the non-opioid pain treatment industry. This non-opioid pain treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The non-opioid pain treatment market size has grown strongly in recent years. It will grow from $55.31 billion in 2025 to $60.32 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increasing prevalence of chronic pain conditions, growing awareness about opioid-related risks, limited availability of non-opioid alternatives, rising orthopedic and musculoskeletal procedures, increasing hospital and clinic infrastructure for pain management.
The non-opioid pain treatment market size is expected to see strong growth in the next few years. It will grow to $84.36 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to development of innovative non-opioid therapeutics, expansion of digital health monitoring and telemedicine for pain, growing adoption of combination therapies, increasing government initiatives for pain management, rising investment in personalized pain care and alternative therapies. Major trends in the forecast period include rising adoption of non-opioid pain management therapies, increased use of medical cannabis and omega-3 fatty acid supplements, growth in topical and injectable pain relief products, expansion of pain management services in hospitals and clinics, integration of non-pharmacological therapies like acupuncture and tens.
The growing number of sports-related injuries is anticipated to boost the non-opioid pain treatment market in the future. Sports-related injuries involve physical harm sustained during or following sports or exercise. This uptick stems from greater involvement in intense sports and leisure pursuits, heightening athletes' vulnerability to bodily trauma. Non-opioid pain treatments benefit these injuries by delivering potent pain alleviation and swelling reduction, sidestepping opioid-related dangers, while aiding quicker healing, better mobility, and secure ongoing care. For instance, in October 2024, Howden Group Holdings Ltd, a UK insurance intermediary, reported that Europe's top five football leagues saw 4,123 injuries in the 2023-24 season-a 4% rise from the year before. Thus, the surge in sports-related injuries is fueling expansion in the non-opioid pain treatment market.
Leading firms in the non-opioid pain treatment market are prioritizing advances in drug formulations, like non-opioid oral therapies, to ensure robust pain relief while curbing opioid-associated risks and dependency. Non-opioid oral treatments are orally taken analgesics excluding opioids, operating via distinct pathways-such as curbing inflammation, altering nerve impulses, or targeting particular receptors-to control pain absent the addiction liability or breathing issues typical of opioids. For example, in July 2025, Vertex Pharmaceuticals Incorporated, a US biotechnology firm, launched JOURNAVX, a pioneering non-opioid option for moderate-to-severe acute pain relief. This innovative therapy precisely targets pain signals, boasts an excellent safety record, and acts swiftly, promoting reliable pain mitigation, lower reliance risks, and superior patient outcomes. It facilitates precise pain control, diminishes addiction chances, and enhances recovery speed alongside life quality for those with acute pain.
In May 2025, Eli Lilly and Company, a US pharmaceutical giant, bought SiteOne Therapeutics Inc. for an undisclosed sum. Through this deal, Eli Lilly seeks to bolster its neuroscience offerings by advancing and marketing STC-004, a non-opioid Nav1.8 blocker, delivering a dependable, addiction-free solution for chronic pain. SiteOne Therapeutics Inc. is a US pharmaceutical firm specializing in non-opioid pain therapies.
Major companies operating in the non-opioid pain treatment market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Limited, Vertex Pharmaceuticals Incorporated, SUN PHARMACEUTICAL INDUSTRIES LIMITED, Perrigo Company Public Limited Company, Dr. Reddy's Laboratories, HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY, Pacira BioSciences Inc, Heron Therapeutics Inc, AFT Pharmaceuticals Limited, Vivozon Pharmaceutical Co. Ltd, Levicept Ltd, Algiax Pharmaceuticals GmbH, Latigo Biotherapeutics Inc, Hyloris Pharmaceuticals SA
North America was the largest region in the non-opioid pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-opioid pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the non-opioid pain treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The non-opioid pain treatment market consists of revenues earned by entities by providing services such as physical therapy services, cognitive and behavioral therapies, and interventional pain management. The market value includes the value of related goods sold by the service provider or included within the service offering. The non-opioid pain treatment market also includes sales of antidepressants, anticonvulsants, and acupuncture kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Non-Opioid Pain Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses non-opioid pain treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for non-opioid pain treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non-opioid pain treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product: Medical Cannabis; Menthol-Containing; Omega 3 Fatty Acid-Containing; Botulinum Toxins; Capsaicin-Derived; Other Products
2) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (Nsaids); Acetaminophen; Local Anesthetics; Antidepressants; Anticonvulsants; Corticosteroids; Other Drug Classes
3) By Route Of Administration: Oral; Topical; Injectable; Other Route Of Administrations
4) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies; Drug Stores; Mail Order Pharmacies
5) By Application: Orthopedic And Musculoskeletal Pain; Postoperative Pain; Cancer Pain; Neuropathic Pain; Other Applications
Subsegments:
1) By Medical Cannabis: Cannabidiol Based Products; Tetrahydrocannabinol Based Products; Combined Cannabinoid Products
2) By Menthol Containing: Topical Creams; Gels; Sprays
3) By Omega 3 Fatty Acid Containing: Fish Oil Derived Supplements; Algae Derived Supplements; Krill Oil Derived Supplements
4) By Botulinum Toxins: Onabotulinumtoxin A; Abobotulinumtoxin A; Incobotulinumtoxin A
5) By Capsaicin Derived: Low Concentration Creams; High Concentration Patches; Nasal Sprays
6) By Other Products: Magnesium Based Products; Acupuncture Devices; Transcutaneous Electrical Nerve Stimulation Devices
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; AbbVie Inc; Novartis AG; GSK plc; Amgen Inc.; Teva Pharmaceutical Industries Limited; Vertex Pharmaceuticals Incorporated; SUN PHARMACEUTICAL INDUSTRIES LIMITED; Perrigo Company Public Limited Company; Dr. Reddy's Laboratories; HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY; Pacira BioSciences Inc; Heron Therapeutics Inc; AFT Pharmaceuticals Limited; Vivozon Pharmaceutical Co. Ltd; Levicept Ltd; Algiax Pharmaceuticals GmbH; Latigo Biotherapeutics Inc; Hyloris Pharmaceuticals SA
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Rising Adoption Of Non-Opioid Pain Management Therapies
4.2.2 Increased Use Of Medical Cannabis And Omega-3 Fatty Acid Supplements
4.2.3 Growth In Topical And Injectable Pain Relief Products
4.2.4 Expansion Of Pain Management Services In Hospitals And Clinics
4.2.5 Integration Of Non-Pharmacological Therapies Like Acupuncture And Tens
5. Non-Opioid Pain Treatment Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Clinics
5.3 Pain Management Centers
5.4 Rehabilitation Centers
5.5 Home Care Providers
6. Non-Opioid Pain Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Non-Opioid Pain Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Non-Opioid Pain Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Non-Opioid Pain Treatment Market Size, Comparisons And Growth Rate Analysis
7.3. Global Non-Opioid Pain Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Non-Opioid Pain Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Non-Opioid Pain Treatment Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Non-Opioid Pain Treatment Market Segmentation
9.1. Global Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived, Other Products
9.2. Global Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Nonsteroidal Anti-Inflammatory Drugs (Nsaids), Acetaminophen, Local Anesthetics, Antidepressants, Anticonvulsants, Corticosteroids, Other Drug Classes
9.3. Global Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Topical, Injectable, Other Route Of Administrations
9.4. Global Non-Opioid Pain Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies
9.5. Global Non-Opioid Pain Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Orthopedic And Musculoskeletal Pain, Postoperative Pain, Cancer Pain, Neuropathic Pain, Other Applications
9.6. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Medical Cannabis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cannabidiol Based Products, Tetrahydrocannabinol Based Products, Combined Cannabinoid Products
9.7. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Menthol Containing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Topical Creams, Gels, Sprays
9.8. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Omega 3 Fatty Acid Containing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.9. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Botulinum Toxins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Onabotulinumtoxin A, Abobotulinumtoxin A, Incobotulinumtoxin A
9.10. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Capsaicin Derived, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Low Concentration Creams, High Concentration Patches, Nasal Sprays
9.11. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Magnesium Based Products, Acupuncture Devices, Transcutaneous Electrical Nerve Stimulation Devices
10. Non-Opioid Pain Treatment Market Regional And Country Analysis
10.1. Global Non-Opioid Pain Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Non-Opioid Pain Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Non-Opioid Pain Treatment Market
12.1. China Non-Opioid Pain Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Non-Opioid Pain Treatment Market
13.1. India Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Non-Opioid Pain Treatment Market
14.1. Japan Non-Opioid Pain Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Non-Opioid Pain Treatment Market
15.1. Australia Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Non-Opioid Pain Treatment Market
16.1. Indonesia Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Non-Opioid Pain Treatment Market
17.1. South Korea Non-Opioid Pain Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Non-Opioid Pain Treatment Market
19.1. South East Asia Non-Opioid Pain Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Non-Opioid Pain Treatment Market
20.1. Western Europe Non-Opioid Pain Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Non-Opioid Pain Treatment Market
21.1. UK Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Non-Opioid Pain Treatment Market
22.1. Germany Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Non-Opioid Pain Treatment Market
23.1. France Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Non-Opioid Pain Treatment Market
24.1. Italy Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Non-Opioid Pain Treatment Market
25.1. Spain Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Non-Opioid Pain Treatment Market
26.1. Eastern Europe Non-Opioid Pain Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Non-Opioid Pain Treatment Market
27.1. Russia Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Non-Opioid Pain Treatment Market
28.1. North America Non-Opioid Pain Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Non-Opioid Pain Treatment Market
29.1. USA Non-Opioid Pain Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Non-Opioid Pain Treatment Market
31.1. South America Non-Opioid Pain Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Non-Opioid Pain Treatment Market
32.1. Brazil Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Non-Opioid Pain Treatment Market
33.1. Middle East Non-Opioid Pain Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Non-Opioid Pain Treatment Market
34.1. Africa Non-Opioid Pain Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Non-Opioid Pain Treatment Market, Segmentation By Product, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Non-Opioid Pain Treatment Market Regulatory and Investment Landscape
36. Non-Opioid Pain Treatment Market Competitive Landscape And Company Profiles
